Poland Contrast Agents Market Outlook to 2022

2017-09-01
Price :
Published : Sep-2017
No. of Pages : 45

Poland Contrast Agents Market Outlook to 2022

Summary

GlobalData’s new report, “Poland Contrast Agents Market Outlook to 2022”, provides key market data on the Poland Contrast Agents market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segments – Computed Tomography (CT) Contrast Agents, Magnetic Resonance Imaging (MRI) Contrast Agents and Ultrasound Contrast Agents (Microbubbles).

*Note: This is an on-demand report and will be delivered within 2-3 business days of the purchase (excluding weekends)

The report also provides company shares and distribution shares data for the market segment, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to market size, company share, pipeline products, news and deals is available in the report.

The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

– Market size for Contrast Agents market segments Computed Tomography (CT) Contrast Agents, Magnetic Resonance Imaging (MRI) Contrast Agents and Ultrasound Contrast Agents (Microbubbles).
– Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market segments. Data is provided from 2008 to 2015 and forecast to 2022.
– 2015 company shares and distribution shares data for Contrast Agents market.
– Global corporate-level profiles of key companies operating within the Poland Contrast Agents market.
– Key players covered include GE Healthcare Limited, Bracco Imaging S.p.A. and Others.

Reasons to buy

– Develop business strategies by identifying the key market segments poised for strong growth in the future.
– Develop market-entry and market expansion strategies.
– Design competition strategies by identifying who-stands-where in the market.
– Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
– What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Filed in: Medical Device
Publisher : GlobalData
More Reports
Title Price Buy Now

Ablation Equipments – Medical Devices Pipeline Assessment, 2017

Ablation Equipments - Medical Devices Pipeline Assessment, 2017 Summary GlobalData's Medical Devices sector report, "Ablation Equipments - Medical Devices Pipeline Assessment, 2017" provides an overview of Ablation Equipments currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Ablation Equipments pipeline products. This report is prepared using data sourced from in-house databases, secondary and primary researc......
$2500

Teva Pharmaceutical Industries Ltd (TEVA) – Medical Equipment – Deals and Alliances Profile

Summary Teva Pharmaceutical Industries Ltd (Teva) carries out the research, development, manufacture and commercialization of generic and specialty medicines. It provides specialty medicines in central nervous system (CNS), respiratory, cancer, women's health and other therapy areas. The company offers generic medicines in a range of dosage forms, including capsules, tablets, injectables, liquids, inhalants, creams and ointments. Teva also provides over-the-counter (OTC) products, as well as active pharmaceutical ingredients (APIs), the essential raw materials to the drug manufacturing industry. It carries out OTC business principally through PGT Healthcare, a consumer healthcare joint venture with The Procter & Gamble Company (P&G). The company conducts its worldwide operations through a......
$250

Shandong Weigao Group Medical Polymer Company Ltd (1066) – Medical Equipment – Deals and Alliances Profile

Summary Shandong Weigao Group Medical Polymer Company Ltd (Weigao) researches, develops, manufactures and sells disposable medical consumables, orthopedic materials and blood purification products. Its products include infusion sets, needles, blood bags, heart eluting stents, blood sampling products and PVC granules. The company's trauma and spinal orthopedic materials and tools include steel plates, screws, spinal series consumables; and artificial joint consumables, which are currently under development. Weigao's medical needle products include intravenous needles, syringe needles, intravenous catheter needles, blood sampling needles and irregular needles. The company offers these products to its customers through healthcare organizations and distributors, hospitals, blood stations, med......
$250

Trovagene Inc (TROV) – Medical Equipment – Deals and Alliances Profile

Summary Trovagene Inc (Trovagene) is a development stage molecular diagnostic company focusing on the development and commercialization of proprietary molecular genetic detection technologies for screening and monitoring cancer and other diseases. Its product portfolio includes liquid biopsy tests that provide important clinical information about mutations associated with common solid tumor cancers such as colorectal, melanoma, pancreas and lung cancer. These tests are used by physicians, third party clinical laboratories and pharmaceutical companies. Trovagene uses its proprietary Precision Cancer Monitoring (PCM) technology to detect and monitor circulating tumor DNA (ctDNA) in urine and blood for the detection and quantitation of oncogene mutations and improvement in cancer care. Trova......
$250

Ypsomed Holding AG (YPSN) – Medical Equipment – Deals and Alliances Profile

Summary Ypsomed Holding AG (Ypsomed) is a medical device company. It designs, develops and manufactures injection systems. Its offers pen injectors, autoinjectors, dual chamber pens and other custom products. The company also offers contract manufacturing, industrial design, human factors engineering and IP landscape management; final assembly infrastructure and registration. Ypsomed offers its solutions to physicians, pharmaceutical and biotech companies. The company's products find application in the treatment of diabetes, infertility, growth disorders and various other clinical indications. The company operates through its subsidiaries and distributors. Ypsomed operates along with its subsidiaries in America's Europe and Asia. Ypsomed is headquartered in Burgdorf, Switzerland. Ypsomed......
$250

Robotic Surgical Systems – Medical Devices Pipeline Assessment, 2017

Robotic Surgical Systems - Medical Devices Pipeline Assessment, 2017 Summary GlobalData's Medical Devices sector report, "Robotic Surgical Systems - Medical Devices Pipeline Assessment, 2017" provides an overview of Robotic Surgical Systems currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Robotic Surgical Systems pipeline products. This report is prepared using data sourced from in-house databases, secondary......
$2500

UCB SA (UCB) – Medical Equipment – Deals and Alliances Profile

Summary UCB SA (UCB) is a biopharmaceutical company that discovers and develops novel medicines and solutions to help treat various diseases. It principally focuses on developing products for the treatment of central nervous system (CNS) and immunology related conditions. The company's key medicines include Cimzia for ankylosing spondylitis, axial spondylarthritis, Crohn's disease, psoriatic arthritis and rheumatoid arthritis; Neupro for Parkinson's disease and restless legs syndrome; and Vimpat, Keppra and Briviact for epilepsy. UCB is also developing new therapies for neurological and immunological diseases. The company operates subsidiaries in the US, Japan, China, Germany, Italy, Spain, France, the UK, Ireland, Belgium, Brazil, Russia, India, Mexico, Turkey and other countries. UCB is......
$250

Simulations Plus Inc (SLP) – Medical Equipment – Deals and Alliances Profile

Summary Simulations Plus Inc (Simulations Plus) develops and markets software for drug discovery and development for the pharmaceutical and biotechnology industries. The company develops absorption, distribution, metabolism, excretion and toxicity modeling and simulation software. It provides preclinical and clinical pharmacometric consulting services to help its customers with regulatory submissions. Simulations Plus's pharmaceutical and chemistry software is licensed to agrochemical, biotechnology, pharmaceutical and food industries, and regulatory agencies worldwide. The company offers training workshops and provides consulting services. Simulations Plus distributes its products and offers services in Australia, China, Europe, India, Japan, North America, New Zealand, South America, Si......
$250

Waters Corporation (WAT) – Medical Equipment – Deals and Alliances Profile

Summary Waters Corporation (Waters) is an analytical instrument manufacturing company. It carries out the design, production, commercialization and servicing of analytical technologies such as high performance liquid chromatography (HPLC), ultra-performance liquid chromatography (UPLC), chromatography columns and chemistry products, mass spectrometry (MS) systems, thermal analysis, rheometry and calorimetry instruments. The company offers its solutions to pharmaceutical, biochemical, life sciences, industrial, academic and governmental institutions working in the areas of research and development, quality assurance and other laboratory applications Waters distributes its products primarily through its facilities located in Taunton, Massachusetts; Wilmslow, England; and Wexford, Ireland. W......
$250

Terumo BCT Inc – Medical Equipment – Deals and Alliances Profile

Summary Terumo BCT Inc (Terumo BCT), a subsidiary of Terumo Corp, provides blood component, therapeutic apheresis, and cellular technologies. The company's product portfolio include automated blood collection system, information system, data collection system, apheresis system, cell processor, cell separation system, pathogen reduction technology system, whole blood processing system, orbisac system, cell expansion system, sterile tubing welder, tube sealing device, blood bag system and ancillary products for blood centers. Its technologies and systems are used in immunotherapy, gene therapy and cell therapy. Terumo BCT caters to blood centers; pharmaceutical, medical device, and veterinary pharmaceutical companies; hospitals; and therapeutic apheresis centers. The company has manufacturi......
$250